Leap Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Cypherpunk Technologies

08/08/2025 16:30

Leap Therapeutics Inc LPTX.OQ LPTX.O is expected to  show no change in quarterly revenue when it reports  results on August 11 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Leap Therapeutics Inc is for a loss of 29 cents per share.

The one available analyst rating on the shares is "hold".

The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated August 8 at 15:30 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)